IRIDEX CORP Files 8-K on Executive/Director Changes
Ticker: IRIX · Form: 8-K · Filed: Apr 8, 2025 · CIK: 1006045
| Field | Detail |
|---|---|
| Company | Iridex Corp (IRIX) |
| Form Type | 8-K |
| Filed Date | Apr 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, filing, corporate-governance
Related Tickers: IRIX
TL;DR
IRIDEX CORP filed an 8-K on 4/7/25 covering exec changes & comp. Watch for details.
AI Summary
On April 7, 2025, IRIDEX CORP filed an 8-K report detailing changes in its executive and director positions. The filing also includes information on compensatory arrangements for certain officers and financial statements/exhibits. Specific details regarding the nature of these changes or the content of the compensatory arrangements are not elaborated upon in the provided text.
Why It Matters
This filing indicates potential shifts in the company's leadership and governance structure, which could impact strategic direction and investor confidence.
Risk Assessment
Risk Level: medium — Changes in executive and director positions can signal underlying issues or strategic shifts that may affect the company's future performance.
Key Numbers
- 000-27598 — SEC File Number (Identifies the company's filings with the SEC.)
- 77-0210467 — IRS Employer Identification Number (Unique tax identification number for the company.)
Key Players & Entities
- IRIDEX CORP (company) — Registrant
- April 7, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 1212 Terra Bella Avenue Mountain View, California 94043 (address) — Principal Executive Offices
- NASDAQ (exchange) — Stock Exchange
FAQ
What specific changes occurred regarding directors or officers?
The filing indicates 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' as an item of report, but the specific names and details of these changes are not provided in the excerpt.
What are the details of the compensatory arrangements mentioned?
The filing lists 'Compensatory Arrangements of Certain Officers' as an item of report, but the specific terms, amounts, or beneficiaries of these arrangements are not detailed in the provided text.
What financial statements or exhibits are included with this filing?
The filing indicates 'Financial Statements and Exhibits' as an item of report, but the specific content of these documents is not described in the excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated April 7, 2025.
What is IRIDEX CORP's principal executive office address?
IRIDEX CORP's principal executive office is located at 1212 Terra Bella Avenue, Mountain View, California 94043.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 8, 2025 regarding IRIDEX CORP (IRIX).